Gilead Sciences Inc

Common Name

Gilead Sciences

Country

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

17,600

Ticker

GILD

Exchange

NASDAQ/NGS

Website

www.gilead.com

Description

Gilead Sciences Inc. is a biopharmaceutical company that focuses on researching, developing, and commercializing innovative medicines in areas of unmet medical need. It is globally recognized for its ... Show more

Financial Statements of Gilead Sciences

Below are the financial statements of Gilead Sciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	9,991^a	6,085^a
Short-term marketable debt securities	0^a	1,179^a
Accounts receivable, net	4,420^a	4,660^a
Inventories	1,710^a	1,787^a
Prepaid and other current assets	3,052^a	2,374^a
Total current assets	19,173^a	16,085^a
Assets	—	—
Property, plant and equipment, net	5,414^a	5,317^a
Long-term marketable debt securities	0^a	1,163^a
Intangible assets, net	19,948^a	26,454^a
Goodwill	8,314^a	8,314^a
Other long-term assets	6,146^a	4,792^a
Total assets	58,995^a	62,125^a
Current liabilities	—	—
Accounts payable	833^a	550^a
Accrued rebates	3,892^a	3,802^a
Current portion of long-term debt and other obligations, net	1,815^a	1,798^a
Other current liabilities	5,464^a	5,130^a
Total current liabilities	12,004^a	11,280^a
Liabilities and stockholders’ equity	—	—
Long-term debt, net	24,896^a	23,189^a
Long-term income taxes payable	830^a	2,039^a
Deferred tax liability	724^a	1,588^a
Other long-term obligations	1,295^a	1,280^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	1^a	1^a
Additional paid-in capital	7,700^a	6,500^a
Accumulated other comprehensive income	132^a	28^a
Retained earnings	11,497^a	16,304^a
Total Gilead stockholders’ equity	19,330^a	22,833^a
Noncontrolling interest	-84^a	-84^a
Total stockholders’ equity	19,246^a	22,749^a
Total liabilities and stockholders’ equity	58,995^a	62,125^a

Verified Sources Behind Gilead Sciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gilead Sciences’s data sources below and access millions more through our Disclosure Search.

a. Gilead Sciences's 10-K 2024

Trace every data point back to Gilead Sciences’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Gilead Sciences Inc

Financial Statements of Gilead Sciences

Verified Sources Behind Gilead Sciences’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Merck & Co Inc

Organon & Co

Biogen Inc

Danaher Corp

Oscar Health Inc

Laboratory Corporation of America Holdings